share_log

サンバイオ:日本におけるSB623慢性外傷性脳損傷(TBI)プログラムの製造および販売承認の状況に関するさらなる最新情報

SanBio: Further updated information regarding the manufacturing and sales approval status of the SB623 chronic traumatic brain injury (TBI) program in Japan.

JPX ·  Jun 12 02:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more